Related Experiment Video
Updated: Jul 13, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
A Decade of the YODA Project: Advancing Clinical Trial Data Sharing through Transparency, Independence, and
Erfan Taherifard1, Jessica D Ritchie1, Molly K Willeford1
1Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Abstract:
The Yale University Open Data Access (YODA) Project, in partnership with Johnson & Johnson since 2014, is an academic-led initiative that promotes independent, transparent, and responsible sharing of clinical trial data. Over the past decade, the YODA Project has made individual participant-level data and supporting documentation from an increasing number of clinical trials available to investigators for independent studies. As of March 31, 2025, there were 482 clinical trials across 86 medical conditions and 49 products available for a median of 6.6 years (interquartile range, 5.0-9.0). A total of 485 data requests have been submitted, with nearly all requests approved (463, 95.5%) or under review (7, 1.4%), and investigators gained data access in a median of 82.5 days (52.0-133.0) from request submission. Among the 463 approved requests, 139 (30.0%) have thus far resulted in at least one peer-reviewed article, yielding 165 articles. The YODA Project experience demonstrates how a data sharing platform has supported a wide range of scientific inquiries and highlights the practical value of responsible data sharing in promoting transparency, building trust, and advancing clinical research.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Discovery: Overview
